Hetzer Medical Indonesia Tbk (MEDS)
IDX
82.00
+2.00 (+2.50%)
Closed
Oct 7, 2026
Day's Range
77.0084.00
52 wk Range
53.00157.00
Financial Statements - MEDS - Hetzer Medical Indonesia Tbk
Revenue
9.36M▲ 90.5%
Net Income
7.54M▲ 209.8%Net Margin 80.5%
EBITDA
8.13M▲ 157.9%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 9.36M | 4.91M | 3.23M | 102K |
| Cost of Goods | 780K | 497K | 315K | 316K |
| Gross Profit | 8.58M | 4.41M | 2.92M | -214K |
 Operating Expense | - | - | - | - |
| Operating Income | 8.13M | 3.15M | 2.38M | 4.51M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 7.54M | 2.43M | 288K | -1.52M |
| Income Tax | 0 | 0 | 0 | 0 |
| Net Income | 7.54M | 2.43M | 288K | -1.52M |
| EPS Basic | 0.45 | 0.15 | 0.02 | -0.09 |
| EPS Diluted | 0.45 | 0.15 | 0.02 | -0.09 |
| Basic Shares Outstanding | 16.75M | 16.75M | 16.75M | 16.96M |
| Diluted Shares Outstanding | 16.75M | 16.75M | 16.75M | 16.96M |
| Ebit | - | - | - | - |
| Ebitda | 8.13M | 3.15M | 2.44M | 4.52M |
| Net Income Continuous Operations | - | - | - | - |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
